Paymentus Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Paymentus Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||
net income | 14,707,000 | 13,813,000 | 13,149,000 | 14,430,000 | 9,364,000 | 7,226,000 | 9,400,000 | 6,377,000 | 5,839,000 | 704,000 | 957,000 | -737,000 | -2,451,000 | 1,718,000 | 4,665,000 | 422,000 |
adjustments to reconcile net income to net cash from operating activities | ||||||||||||||||
depreciation and amortization | 10,483,000 | 10,740,000 | 9,657,000 | 9,321,000 | 8,969,000 | 8,537,000 | 8,286,000 | 7,772,000 | 7,303,000 | 7,239,000 | 6,545,000 | 6,158,000 | 5,886,000 | 5,474,000 | 4,708,000 | 3,647,000 |
deferred income taxes | -978,000 | -1,013,000 | -16,000 | -1,510,000 | 85,000 | 92,000 | 135,000 | 91,000 | 95,000 | 92,000 | 350,000 | -9,000 | -4,728,000 | 1,406,000 | -3,351,000 | 278,000 |
stock-based compensation | 4,728,000 | 3,042,000 | 1,566,000 | 3,168,000 | 3,323,000 | 2,933,000 | 2,499,000 | 2,456,000 | 2,276,000 | 2,159,000 | 2,114,000 | 2,002,000 | 1,344,000 | 1,276,000 | 1,251,000 | 754,000 |
amortization of capitalized warrants cost | 565,000 | 559,000 | ||||||||||||||
non-cash lease expense | 585,000 | 573,000 | 583,000 | 608,000 | 692,000 | 506,000 | 443,000 | 442,000 | 442,000 | 462,000 | 432,000 | 583,000 | 365,000 | 755,000 | 366,000 | 483,000 |
amortization of capitalized contract acquisition cost | 455,000 | 418,000 | ||||||||||||||
benefit from expected credit losses and credit adjustments | 1,598,000 | 1,440,000 | ||||||||||||||
other non-cash adjustments | 0 | 0 | ||||||||||||||
change in operating assets and liabilities | ||||||||||||||||
accounts and other receivables | 1,834,000 | 18,386,000 | -12,004,000 | -21,068,000 | -5,999,000 | -7,850,000 | -1,731,000 | -7,806,000 | 9,198,000 | -8,333,000 | -5,144,000 | -9,938,000 | -1,123,000 | -8,082,000 | -6,922,000 | -2,870,000 |
prepaid expenses and other assets | 1,363,000 | -377,000 | ||||||||||||||
accounts payable | -3,175,000 | 5,691,000 | -524,000 | 6,399,000 | 2,157,000 | 5,793,000 | 1,738,000 | 2,929,000 | -1,947,000 | 3,297,000 | 1,791,000 | -230,000 | -1,711,000 | 4,916,000 | -462,000 | 4,301,000 |
accrued and other liabilities | 4,699,000 | -7,120,000 | ||||||||||||||
operating lease liabilities | -621,000 | -604,000 | -597,000 | -583,000 | -627,000 | -446,000 | -453,000 | -448,000 | -447,000 | -469,000 | -434,000 | -456,000 | -172,000 | -770,000 | -372,000 | -498,000 |
contract liabilities | 315,000 | 401,000 | 786,000 | -830,000 | -1,081,000 | 28,000 | -1,593,000 | -625,000 | -204,000 | 2,061,000 | 3,219,000 | 5,000 | 132,000 | -57,000 | 91,000 | 82,000 |
income taxes receivable, net of payable | -5,079,000 | 4,492,000 | 1,178,000 | -3,091,000 | -4,353,000 | 3,008,000 | 1,992,000 | 384,000 | -400,000 | -1,018,000 | 1,059,000 | 281,000 | 4,855,000 | -4,651,000 | -1,176,000 | -923,000 |
net cash from operating activities | 31,479,000 | 50,441,000 | 27,913,000 | 6,737,000 | 18,030,000 | 10,954,000 | 24,441,000 | 13,143,000 | 26,481,000 | 4,763,000 | 14,724,000 | -1,949,000 | 3,844,000 | 3,248,000 | 136,000 | 6,600,000 |
capex | -9,004,000 | -9,338,000 | -8,962,000 | -8,948,000 | -9,274,000 | -9,392,000 | -8,449,000 | -158,000 | -286,000 | -8,286,000 | -7,600,000 | -8,161,000 | -7,998,000 | -7,261,000 | -5,981,000 | -4,998,000 |
free cash flows | 22,475,000 | 41,103,000 | 18,951,000 | -2,211,000 | 8,756,000 | 1,562,000 | 15,992,000 | 12,985,000 | 26,195,000 | -3,523,000 | 7,124,000 | -10,110,000 | -4,154,000 | -4,013,000 | -5,845,000 | 1,602,000 |
cash flows from investing activities | ||||||||||||||||
purchases of property and equipment | -116,000 | -60,000 | -81,000 | -72,000 | -188,000 | -116,000 | -89,000 | -158,000 | -286,000 | -67,000 | -94,000 | -368,000 | -265,000 | -530,000 | -154,000 | -261,000 |
purchases of interest-bearing deposits | ||||||||||||||||
proceeds from matured interest-bearing deposits | 496,000 | 1,051,000 | 940,000 | 1,376,000 | 588,000 | 602,000 | ||||||||||
capitalized internal-use software development costs | -8,888,000 | -9,278,000 | -8,881,000 | -8,876,000 | -9,086,000 | -9,276,000 | -8,360,000 | -8,219,000 | -7,506,000 | -7,793,000 | -7,733,000 | -6,731,000 | -5,827,000 | -4,737,000 | ||
net cash from investing activities | -9,421,000 | -8,287,000 | -9,144,000 | -8,828,000 | -9,276,000 | -9,513,000 | -8,449,000 | -8,886,000 | -8,678,000 | -8,286,000 | -10,892,000 | -8,286,000 | -8,098,000 | -7,284,000 | -6,391,000 | -62,118,000 |
cash flows from financing activities | ||||||||||||||||
proceeds from exercise of stock-based awards | 40,000 | 51,000 | 182,000 | 19,000 | 37,000 | 100,000 | 181,000 | 234,000 | 196,000 | 5,000 | 21,000 | |||||
payments of taxes withheld on net settled vesting of restricted stock units | -1,821,000 | -1,943,000 | ||||||||||||||
settlement of holdback liability related to prior acquisitions | 0 | -39,000 | 0 | -506,000 | ||||||||||||
net cash from financing activities | -1,781,000 | -1,892,000 | 182,000 | -20,000 | 37,000 | -406,000 | 181,000 | 234,000 | -488,000 | -1,122,000 | -80,223,000 | 18,722,000 | 21,855,000 | 2,363,000 | -7,461,000 | 4,724,000 |
effect of exchange rate changes on cash and cash equivalents and restricted cash | 120,000 | -25,000 | -325,000 | 16,000 | -63,000 | -78,000 | 130,000 | -67,000 | 130,000 | -17,000 | ||||||
net increase in cash, cash equivalents and restricted cash | 20,397,000 | 40,237,000 | 18,626,000 | -2,095,000 | 8,728,000 | 957,000 | 16,303,000 | 4,424,000 | -76,230,000 | 8,255,000 | 17,494,000 | -1,663,000 | -13,748,000 | |||
cash and cash equivalents and restricted cash at the beginning of period | 0 | 209,411,000 | 0 | 0 | 0 | 183,195,000 | ||||||||||
cash and cash equivalents and restricted cash at the end of period | 20,397,000 | 249,648,000 | 18,626,000 | -2,095,000 | 8,728,000 | 184,152,000 | ||||||||||
reconciliation of cash and cash equivalents and restricted cash: | ||||||||||||||||
cash and cash equivalents at the beginning of period | 0 | 205,900,000 | 0 | 0 | 0 | 179,361,000 | ||||||||||
restricted cash at the beginning of period | 0 | 3,511,000 | 0 | 0 | 0 | 3,834,000 | ||||||||||
cash and cash equivalents at the end of period | 20,573,000 | 245,849,000 | 18,358,000 | -1,268,000 | 8,672,000 | 180,138,000 | ||||||||||
restricted cash at the end of period | -176,000 | 3,799,000 | 268,000 | -827,000 | 56,000 | 4,014,000 | ||||||||||
supplemental disclosure of cash flow information: | ||||||||||||||||
cash paid for income taxes, net of refunds | 9,748,000 | 508,000 | 4,673,000 | 7,312,000 | 434,000 | 449,000 | 653,000 | 616,000 | 251,000 | 237,000 | 11,000 | 173,000 | 179,000 | 1,358,000 | ||
non-cash investing activities: | ||||||||||||||||
right-of-use assets obtained in exchange of operating lease obligations | 370,000 | -1,000 | 97,000 | 0 | 0 | 1,356,000 | ||||||||||
unpaid capitalized internal-use software development costs and equipment in accounts payable | 102,000 | |||||||||||||||
accrued liabilities | 7,356,000 | 3,921,000 | 4,048,000 | -8,166,000 | 2,100,000 | 3,297,000 | 3,640,000 | -2,749,000 | 1,010,000 | -225,000 | 1,753,000 | 862,000 | -193,000 | -394,000 | ||
business combinations, net of cash and restricted cash acquired | -280,000 | |||||||||||||||
other intangible assets acquired | -32,000 | -125,000 | -100,000 | -23,000 | ||||||||||||
financial institution funds in-transit | -77,601,000 | 18,276,000 | 22,543,000 | 3,339,000 | -4,628,000 | |||||||||||
payments on other financing obligations | 0 | 0 | -684,000 | -1,025,000 | -2,576,000 | -655,000 | -916,000 | -915,000 | -3,080,000 | -715,000 | ||||||
payments on finance leases | 0 | 0 | 0 | -102,000 | -67,000 | -66,000 | -61,000 | -74,000 | -68,000 | -68,000 | ||||||
restricted funds held for financial institutions at the beginning of period | ||||||||||||||||
amortization of contract asset | 514,000 | 430,000 | 451,000 | 802,000 | 756,000 | 745,000 | 696,000 | 711,000 | 529,000 | 351,000 | 467,000 | 246,000 | 246,000 | |||
benefit from expected credit losses | -44,000 | 110,000 | 48,000 | 210,000 | 112,000 | 5,000 | -239,000 | |||||||||
prepaid expenses and other current and long-term assets | -4,498,000 | 912,000 | -993,000 | 613,000 | -2,594,000 | -64,000 | 861,000 | 2,065,000 | 56,000 | -749,000 | -161,000 | 1,179,000 | 1,072,000 | |||
purchase of interest-bearing deposits | -1,256,000 | -590,000 | -723,000 | |||||||||||||
other non-recurring income | -213,000 | |||||||||||||||
property and equipment purchases in accounts payable | 87,000 | 3,000 | -106,000 | 119,000 | -40,000 | 123,000 | 121,000 | |||||||||
software purchases in accounts payable | 16,000 | |||||||||||||||
proceeds from initial public offering, net of underwriter's discounts and commissions | 0 | 0 | ||||||||||||||
proceeds from private placement | 0 | 0 | ||||||||||||||
redemption of series a preferred stock | 0 | 0 | ||||||||||||||
payment of dividends on series a preferred stock | 0 | 0 | ||||||||||||||
proceeds from repayment of related party loan | 0 | 0 | ||||||||||||||
payments of deferred offering costs | 0 | -1,105,000 | ||||||||||||||
cash and cash equivalents and restricted cash beginning of period | 0 | 0 | 0 | 149,685,000 | ||||||||||||
cash and cash equivalents and restricted cash end of period | 16,303,000 | 4,424,000 | 17,445,000 | 145,023,000 | ||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 0 | 147,334,000 | ||||||||||||
restricted cash at beginning of period | 0 | 0 | 0 | 2,351,000 | ||||||||||||
restricted funds held for financial institutions at beginning of period | ||||||||||||||||
cash and cash equivalents and restricted cash at beginning of period | 0 | 0 | 0 | 149,685,000 | ||||||||||||
cash and cash equivalents at end of period | 17,299,000 | 2,994,000 | 15,431,000 | 143,637,000 | ||||||||||||
restricted cash at end of period | -996,000 | 1,430,000 | 2,014,000 | 1,386,000 | ||||||||||||
restricted funds held for financial institutions at end of period | ||||||||||||||||
cash and cash equivalents and restricted cash at end of period | 16,303,000 | 4,424,000 | 17,445,000 | 145,023,000 | ||||||||||||
prepaid insurance funded through short-term borrowings | 200,000 | 3,076,000 | 0 | 3,621,000 | ||||||||||||
issuance of warrant and change in estimate of warrants expected to vest | 0 | |||||||||||||||
capitalized software development costs | ||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -4,662,000 | |||||||||||||||
benefit from credit losses | 49,000 | 32,000 | 92,000 | 95,000 | ||||||||||||
foreign currency effect on cash, cash equivalents and restricted cash | 161,000 | -232,000 | -107,000 | 10,000 | -32,000 | |||||||||||
cash, cash equivalents and restricted cash | ||||||||||||||||
beginning of period | 0 | 0 | 0 | 201,829,000 | 0 | 0 | ||||||||||
end of period | -76,230,000 | 8,255,000 | 17,494,000 | 200,166,000 | -13,748,000 | -50,813,000 | ||||||||||
fair value of class a common stock issued for acquisitions | 1,372,000 | |||||||||||||||
business acquisition liability in accrued liabilities and finance leases and other finance obligations, net of current portion | -1,373,000 | |||||||||||||||
non-cash financing activities: | ||||||||||||||||
property and equipment acquired through finance lease liabilities | ||||||||||||||||
intangibles acquired through other financing obligations | ||||||||||||||||
proceeds from exercise of stock options | 289,000 | 13,000 | ||||||||||||||
issuance of warrant | 0 | 304,000 | ||||||||||||||
unpaid deferred offering costs | ||||||||||||||||
change in operating assets and liabilities, net of impact of business combination | ||||||||||||||||
proceeds from issuance of common shares | ||||||||||||||||
proceeds from issuance of series a preferred shares | ||||||||||||||||
payment on debt assumed in acquisitions | ||||||||||||||||
foreign currency effect on cash and cash equivalents | ||||||||||||||||
net increase in cash and cash equivalents | ||||||||||||||||
cash and cash equivalents | ||||||||||||||||
property and equipment purchases in accounts payable and other payables |
We provide you with 20 years of cash flow statements for Paymentus stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Paymentus stock. Explore the full financial landscape of Paymentus stock with our expertly curated income statements.
The information provided in this report about Paymentus stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.